Giesbrecht E - Search Results

1

Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia.

Koren G, Langevin AM, Olivieri N, Giesbrecht E, Zipursky A, Greenberg M. Koren G, et al. Among authors: giesbrecht e. Am J Dis Child. 1990 Oct;144(10):1135-7. doi: 10.1001/archpedi.1990.02150340081028. Am J Dis Child. 1990. PMID: 2403095

2

Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia.

Koren G, Ferrazzini G, Sohl H, Robieux I, Johnson D, Giesbrecht E. Koren G, et al. Among authors: giesbrecht e. Chronobiol Int. 1992 Dec;9(6):434-8. doi: 10.3109/07420529209064555. Chronobiol Int. 1992. PMID: 1473196

3

Diurnal variation of methotrexate disposition in children with acute leukaemia.

Ferrazzini G, Sohl H, Robieux I, Johnson D, Giesbrecht E, Koren G. Ferrazzini G, et al. Among authors: giesbrecht e. Eur J Clin Pharmacol. 1991;41(5):425-7. doi: 10.1007/BF00626363. Eur J Clin Pharmacol. 1991. PMID: 1761069

4

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

Koren G, Ferrazini G, Sulh H, Langevin AM, Kapelushnik J, Klein J, Giesbrecht E, Soldin S, Greenberg M. Koren G, et al. Among authors: giesbrecht e. N Engl J Med. 1990 Jul 5;323(1):17-21. doi: 10.1056/NEJM199007053230104. N Engl J Med. 1990. PMID: 2355954 Free article.

5

Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics.

Berkovitch M, Matsui D, Zipursky A, Blanchette VS, Verjee Z, Giesbrecht E, Saunders EF, Evans WE, Koren G. Berkovitch M, et al. Among authors: giesbrecht e. Med Pediatr Oncol. 1996 Feb;26(2):85-9. doi: 10.1002/(SICI)1096-911X(199602)26:2<85::AID-MPO3>3.0.CO;2-Q. Med Pediatr Oncol. 1996. PMID: 8531858

6

Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children.

Stone J, Bentur Y, Zalstein E, Soldin S, Giesbrecht E, Koren G. Stone J, et al. Among authors: giesbrecht e. J Pediatr. 1990 Aug;117(2 Pt 1):321-5. doi: 10.1016/s0022-3476(05)80555-4. J Pediatr. 1990. PMID: 2166153

7

Interpretation of excessive levels of inhaled tobramycin.

Bentur Y, Hummel D, Roifman CM, Giesbrecht E, Koren G. Bentur Y, et al. Among authors: giesbrecht e. Ther Drug Monit. 1989;11(1):109-10. doi: 10.1097/00007691-198901000-00022. Ther Drug Monit. 1989. PMID: 2911844 No abstract available.

8

Evaluation of therapeutic drug monitoring of methotrexate in saliva of children with rheumatic diseases.

Press J, Berkovitch M, Laxer R, Giesbrecht E, Verjee Z, Silverman E, Klein J, Koren G. Press J, et al. Among authors: giesbrecht e. Ther Drug Monit. 1995 Jun;17(3):247-50. doi: 10.1097/00007691-199506000-00006. Ther Drug Monit. 1995. PMID: 7624920

9

The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside.

Koren G, Klein J, Bentur Y, Giesbrecht E. Koren G, et al. Among authors: giesbrecht e. Clin Invest Med. 1989 Oct;12(5):279-84. Clin Invest Med. 1989. PMID: 2513154

10

Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.

Ito S, Gow R, Verjee Z, Giesbrecht E, Dodo H, Freedom R, Tonn GR, Axelson JE, Zalzstein E, Rosenberg HC, Koren G. Ito S, et al. Among authors: giesbrecht e. J Clin Pharmacol. 1998 Jun;38(6):496-501. doi: 10.1002/j.1552-4604.1998.tb05786.x. J Clin Pharmacol. 1998. PMID: 9650538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters